1: Volk J, Kleine HD, Buthmann U, Freund M. Oxidative burst measurement in patients treated with cytostatics: influence of G-CSF and role as a prognostic factor. Ann Hematol. 2000 Apr;79(4):187-97. PubMed PMID: 10834506.
2: Jansen M, Dykstra M, Lee JI, Stables J, Topley P, Knick VC, Mullin RJ, Duch DS, Smith GK. Effect of purine synthesis inhibition on WiDr spheroids in vitro or on WiDr or colon 38 tumors in vivo. Complete growth inhibition but not regression. Biochem Pharmacol. 1994 Mar 15;47(6):1067-78. PubMed PMID: 8147906.
3: Pezzoni G, Grandi M, Biasoli G, Capolongo L, Ballinari D, Giuliani FC, Barbieri B, Pastori A, Pesenti E, Mongelli N, et al. Biological profile of FCE 24517, a novel benzoyl mustard analogue of distamycin A. Br J Cancer. 1991 Dec;64(6):1047-50. PubMed PMID: 1764367; PubMed Central PMCID: PMC1977856.
4: Pharmacologic and clinical studies on n-formyl-sarcolysine. Chinas Med. 1967 Aug;8:606-23. PubMed PMID: 5588881.
5: SUNG CY, CHU HY, LI CH. PHYSIOLOGIC DISPOSITION OF N-FORMYL-SARCOLYSINE-C14 IN NORMAL AND TUMOR-BEARING ANIMALS. Chin Med J (Engl). 1965 Feb;84:84-91. PubMed PMID: 14285313.
6: WU HH, CHOU CC, SUN Y, FENG HY. A PRELIMINARY CLINICAL REPORT ON THE EFFICACY OF N-FORMYL SARCOLYSIN IN THE TREATMENT OF SOME MALIGNANT DISEASES. Acta Unio Int Contra Cancrum. 1964;20:357-9. PubMed PMID: 14151928.
7: CHI HC, WANG CK, HAN J. [THE EFFECT OF N-FORMYL-SARCOLYSIN UPON P32 INCORPORATION INTO NUCLEIC ACIDS OF NORMAL TISSUES AND TRANSPLANTABLE TUMORS.]. Sheng Li Xue Bao. 1963 Sep;26:264-70. Chinese. PubMed PMID: 14089287.
8: HAN J, WANG CK, CHI HC, LI KT, LIU KT, CHANG HY, HO S, FAN LL, LEI HP. [STUDIES ON ANTITUMOR DRUGS. VIII. THE ANTITUMOR EFFECT OF THE ETHYL ESTER OF N-FORMYL-SARCOLYSIN- PHENYLALANINE ON EXPERIMENTAL TUMORS.]. Yao Xue Xue Bao. 1963 Aug;10:460-5. Chinese. PubMed PMID: 14081390.
9: JUEI H, CHEN-KANG W, SHIH H, HSIU-CHUAN C, KENG-T'AO L, T'IEN-HSI C, HUEI-YAN C, LI-LI F. Effect of N-formyl-sarcolysine on experimental tumors. Chin Med J. 1962 Sep;81:574-84. PubMed PMID: 14029821.
10: JUEI H, CHEN-KANG W, SHIH H, HSIU-CHUAN C, KENG-T'AO L, T'IEN-HSI C, HUEI-YAN C, LI-LI F. Effect of N-formyl-sarcolysine on experimental tumors. Chin Med J. 1962 Sep;81:574-84. PubMed PMID: 13957970.

Chemical
CAS Num	7789-59-5
Chemical Formula	C14H18Cl2N2O3
Molecular Weight	333.21
IUPAC Chemical Name	3-[4-[bis(2-chloroethyl)amino]phenyl]-2-formamidopropanoic acid
Exact Mass	332.06945
Elemental Analysis	C, 50.46; H, 5.44; Cl, 21.28; N, 8.41; O, 14.40
Synonym	NFormylmelphalan; NFormylLsarcolysin; NFormylLpsarcolysin; CB 3208; NSC 37024; NSC37024; LS15879.
Solubility	Soluble in DMSO, not in water
SMILES Code	O=C(O)C(NC=O)CC1=CC=C(N(CCCl)CCCl)C=C1
Biological
Targets and Effects	N/A
Pathways	alkylating agent
Physical
Appearance	Solid powder
Purity	>98% (or refer to the Certificate of Analysis)
Shipping Condition	Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition	Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Shelf Life	>2 years if stored properly